PepGen Ltd (PEPG)

Currency in USD
1.32
-0.01(-0.75%)
Closed·
After Hours
1.320.00(0.00%)
·
PEPG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PEPG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.301.39
52 wk Range
0.8810.15
Key Statistics
Prev. Close
1.33
Open
1.35
Day's Range
1.3-1.39
52 wk Range
0.88-10.15
Volume
99.34K
Average Volume (3m)
232.02K
1-Year Change
-86.44%
Book Value / Share
2.81
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PEPG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.00
Upside
+506.06%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

PepGen Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

PepGen Ltd Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.

Compare PEPG to Peers and Sector

Metrics to compare
PEPG
Peers
Sector
Relationship
P/E Ratio
−0.4x−3.7x−0.5x
PEG Ratio
−0.18−0.130.00
Price/Book
0.5x2.2x2.6x
Price / LTM Sales
-6.9x3.3x
Upside (Analyst Target)
-160.3%43.5%
Fair Value Upside
Unlock1.8%6.3%Unlock

Analyst Ratings

4 Buy
0 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.00
(+506.06% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.92 / -0.72
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PEPG Income Statement

People Also Watch

6.32
REPL
+10.68%
14.5300
INKT
+9.91%
3.66
ALT
+2.23%
0.532
WINT
-8.54%

FAQ

What Stock Exchange Does PepGen Trade On?

PepGen is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for PepGen?

The stock symbol for PepGen is "PEPG."

What Is the PepGen Market Cap?

As of today, PepGen market cap is 43.52M.

What Is PepGen's Earnings Per Share (TTM)?

The PepGen EPS (TTM) is -3.14.

When Is the Next PepGen Earnings Date?

PepGen will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is PEPG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PepGen Stock Split?

PepGen has split 0 times.

How Many Employees Does PepGen Have?

PepGen has 79 employees.

What is the current trading status of PepGen (PEPG)?

As of 05 Aug 2025, PepGen (PEPG) is trading at a price of 1.32, with a previous close of 1.33. The stock has fluctuated within a day range of 1.30 to 1.39, while its 52-week range spans from 0.88 to 10.15.

What Is PepGen (PEPG) Price Target According to Analysts?

The average 12-month price target for PepGen is USD8, with a high estimate of USD14 and a low estimate of USD1. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +506.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.